We are live on ! Find out more
AEMD icon

Aethlon Medical

12 hedge funds and large institutions have $816K invested in Aethlon Medical in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

89% more capital invested

Capital invested by funds: $431K → $816K (+$385K)

0% more ownership

Funds ownership: 0%0% (+0%)

8% less funds holding

Funds holding: 1312 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q4 2020 in Review

12 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2020, worth a combined $816K — up 89% from $431K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AEMD and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.

The largest buyer was Geode Capital Management, adding an estimated $81.5K. The largest seller was Morgan Stanley, exiting entirely with an estimated $111K sold.

  • 12 institutional investors held Aethlon Medical (AEMD) as of Q4 2020, down from 13 in Q3 2020.
  • Funds reported $816K of Aethlon Medical stock for Q4 2020, up 89% quarter-over-quarter.
  • 2 funds opened new Aethlon Medical positions in Q4 2020 and 3 closed out, a net change of -1 holder.
  • The largest Aethlon Medical buyer in Q4 2020 was Geode Capital Management, an estimated $81.5K added.
  • The largest Aethlon Medical seller in Q4 2020 was Morgan Stanley, an estimated $111K sold.

Based on aggregated 13F filings for Q4 2020.